Savera Pharmaceuticals

Aurangabad, India Founded: 1998 • Age: 28 yrs
Contract manufacturing of liquid oral and powder formulations for pharmaceuticals.

About Savera Pharmaceuticals

Savera Pharmaceuticals is a Healthcare company based in Aurangabad (India) founded in 1998. Contract manufacturing of liquid oral and powder formulations for pharmaceuticals. It operates on a B2B and Export Manufacturing model in Healthcare and Agriculture sectors. Its Indian entity Savera Pharmaceuticals Private Limited reported revenue of β‚Ή11.53 Cr. Savera Pharmaceuticals offers products and services including Liquid Orals, Powder Formulations, and Sanitizers. Its focus areas include Pharmaceuticals, Manufacturing, Formulations and Food and Agriculture Tech. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

Savera Pharmaceuticals, established in 1998, focuses on contract manufacturing of liquid oral formulations like syrups and suspensions, as well as powder formulations. Based in Aurangabad, India, they operate a WHO-GMP and ISO 9001 certified facility with a capacity for 200,000 bottles and 250,000 sachets per day. They serve multinational companies in domestic and semi-regulated markets, exporting to over 15 countries, and emphasize quality, innovation, and technical expertise in product development.

  • Headquarters Aurangabad, India
  • Sectors
    Healthcare
    Agriculture
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website saverapharma.com
  • Social LinkedIn Facebook
  • Legal Name Savera Pharmaceuticals Private Limited
  • Date of Incorporation 27 Feb, 1996
  • Jurisdiction Aurangabad, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹11.53 Cr

    FY 2025 · +87% YoY

  • Net Profit
    ₹98.8 Lakh

    FY 2025 · 9% margin

  • EBITDA
    ₹2.38 Cr

    FY 2025 · 21% margin

Products & Services of Savera Pharmaceuticals

Savera Pharmaceuticals offers a comprehensive portfolio of products and services, including Liquid Orals, Powder Formulations, and Sanitizers.

Liquid Orals
Pharmaceutical Products

Manufacturing of syrups, suspensions, and elixirs for health applications.

Powder Formulations
Pharmaceutical Products

Production of powders like multivitamins and ORS for medical use.

Sanitizers
Hygiene Products

Alcohol-based sanitizers to support hygiene and fight infections.

Board of directors of Savera Pharmaceuticals Private Limited (Savera Pharmaceuticals)

Savera Pharmaceuticals Private Limited is the primary company behind Savera Pharmaceuticals. The board of Savera Pharmaceuticals Private Limited currently have 5 directors; the longest-serving is Anil Moreshwar Save, appointed in 1996. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Anil Moreshwar Save
DIN 00561935
Director27 Feb 199630 yrs 7 moSavera Pharmaceuticals Private Limited
Rajeev Yadav Churi
DIN 00561987
Director27 Feb 199630 yrs 7 moSavera Pharmaceuticals Private Limited
Ajit Moreshwar Save
DIN 00561875
Director27 Feb 199630 yrs 7 moSavera Pharmaceuticals Private Limited
Anjali Anil Save
DIN 02863357
Director30 Sep 20188 yrsSavera Pharmaceuticals Private Limited
Arpit Anil Save
DIN 02863344
Director17 Jan 20242 yrs 9 moSavera Pharmaceuticals Private Limited

Financials of Savera Pharmaceuticals

Figures of Savera Pharmaceuticals Private Limited, the primary company behind Savera Pharmaceuticals, for FY 2025. Revenue was ₹11.53 Cr (+87% year on year). Net profit was ₹98.8 Lakh (9% margin). EBITDA was ₹2.38 Cr (21% margin). Revenue has grown at a compounded annual rate of +18% over three years and +5% over five years.

  • ₹11.53 CrRevenue · FY 2025 · +87% YoY
  • ₹98.8 LakhNet profit · 9% margin
  • ₹2.38 CrEBITDA · 21% margin
  • ₹1.90 CrPaid-up capital
  • 32Employees (provident fund records)
  • +18%Revenue CAGR, 3 years
  • +5%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Savera Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Savera Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Savera Pharmaceuticals

Savera Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of Savera Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Savera Pharmaceuticals

Savera Pharmaceuticals was founded in 1998.

Savera Pharmaceuticals is headquartered in Aurangabad, India. It is registered at Aurangabad, Maharashtra, India.

The primary company behind Savera Pharmaceuticals, Savera Pharmaceuticals Private Limited, reported revenue of β‚Ή11.53 Cr for FY 2025, up 87% year on year.

Savera Pharmaceuticals, established in 1998, focuses on contract manufacturing of liquid oral formulations like syrups and suspensions, as well as powder formulations. Based in Aurangabad, India, they operate a WHO-GMP and ISO 9001 certified facility with a capacity for 200,000 bottles and 250,000 sachets per day. They serve multinational companies in domestic and semi-regulated markets, exporting to over 15 countries, and emphasize quality, innovation, and technical expertise in product development.

Savera Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Savera Pharmaceuticals offers Liquid Orals, Powder Formulations, and Sanitizers.

Savera Pharmaceuticals operates through Savera Pharmaceuticals Private Limited.

The legal entities of Savera Pharmaceuticals currently have 5 directors, including Anil Moreshwar Save, Rajeev Yadav Churi, Ajit Moreshwar Save and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available